Recent Updates
Recently added Catalysts
GEHC Positive Sentiment

GE HealthCare to showcase AI and digital leadership at HIMSS 2026

Key Takeaway: GE HealthCare will present its latest innovations at the HIMSS 2026 conference in Las Vegas, focusing on AI and digital solutions to enhance patient care. The company aims to address workforce shortages and streamline healthcare operations through advanced technology. GE HealthCare continues to lead in AI-enabled medical devices, with numerous FDA authorizations. The event will highlight their commitment to improving data exchange and clinical decision-making.
Price reaction · baseline $79.02 (2026-03-04 close) · hit pre-market · clean, no other GEHC news in the window
day 0 close · peak
-2.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Showcasing innovative healthcare technologies at HIMSS 2026.
  • Leading the industry in AI innovation with 115 FDA authorizations.
  • Focus on reducing clinical complexities and improving patient care.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+32%
120-day peak, hindsight
Typical move
2.5%
average across 3 past catalysts
Lead asset
Perflutren lipid microsphere
Phase 3 · Prostate Carcinoma

Full Press Release Details

LAS VEGAS--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) will showcase innovations moving healthcare forward at the Health Information and Management Systems Society (HIMSS) Global Health Conference & Exhibition 2026 in Las Vegas from March 9-12, 2026. This year, GE HealthCare will spotlight meaningful technology transforming the way healthcare professionals approach patient care, from imaging operations and fleet management to enterprise solutions, ultrasound, and patient care technologies.
The healthcare industry continues to confront worsening workforce gaps with projections showing multi‑specialty shortages through 2038 and demand projected to outpace supply in multiple health professions, placing sustained pressure on health systems to deliver care more efficiently.iTo address today’s challenges and support clinicians tomorrow, GE HealthCare solutions are designed to reduce clinical and operational complexities and help providers quickly turn data into insights to help streamline workflows.
“The future of healthcare depends on how effectively we remove complexity and empower clinicians,” said Scott Miller, CEO, Solutions for Enterprise Imaging (SEI), GE HealthCare. “By anticipating what healthcare teams need next, we’re accelerating cloud and AI‑enabled solutions that help them work smarter, make faster, better‑informed decisions, and deliver more connected, accessible care.”
GE HealthCare continues to lead the industry in artificial intelligence (AI) innovation, topping a U.S. Food and Drug Administration list of AI-enabled medical device authorizations, with 115 authorizations to date.iiAt HIMSS 2026, GE HealthCare will exhibit several solutions pushing forward the boundaries of innovation.
GE HealthCare is continuing to work across the industry to enable real-time data exchange between medical devices by joining the Health Level Seven®International (HL7®) Caliper FHIR®Accelerator as a founding member. Caliper is an implementation community focused on improving how data from medical and personal health devices is exchanged, integrated, and used across healthcare systems. The coalition’s work will enable consistent integration of high‑fidelity device data into EHRs, analytics, and AI‑enabled applications to better support clinical decision‑making and care delivery across settings and devices.
Key innovations to be showcased at HIMSS 2026:
GE HealthCare activities at HIMSS 2026:
About GE HealthCare Technologies Inc.
GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.
GE HealthCare is proud to be among2026FortuneWorld’s Most Admired Companies™.
Follow us onLinkedIn,Facebook,Instagram, or visit our website for ourlatest newsandperspectives.
iHealth Resources and Services Administration (HRSA) National Center for Health Workforce Analysis (NCHWA) Report:Health Workforce Projections, 2023–2038.https://data.hrsa.gov/topics/health-workforce/nchwa/workforce-projections.
iiU.S. Food and Drug Administration. “Artificial Intelligence-Enabled Medical Devices.” https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-enabled-medical-devices.
iiiCareIntellect Perinatal formerly Mural Perinatal Surveillance, a 510(k)-cleared device in the U.S. is the product name. CareIntellect for Perinatal may appear in descriptive content. Not all features and functionality are available in all markets. Product configurations are subject to change without notice. Availability is dependent on regional regulatory authorizations.
ivGenesis Radiology Workspace consists of Genesis View, Workflow Manager, Enterprise Archive, App Orchestrator. Genesis View is not available for sale in the United States. This product cannot be placed on the market or put into service until it has been made to comply with CE marking. Genesis Radiology Workspace is not yet commercially available for USA and UK.
vRemote scanning, training and collaboration can be fulfilled by either nCommand™ Lite by IONIC Health or Digital Expert Access with Remote Scanning for MR by GE HealthCare. Consult your sales representative for availabilities in your region.
viNot for diagnostic use

Frequently Asked Questions

What will GE HealthCare showcase at HIMSS 2026?

GE HealthCare will showcase innovations in AI and digital solutions for patient care.

How many FDA authorizations does GE HealthCare have?

GE HealthCare has received 115 FDA authorizations for AI-enabled medical devices.

What is the focus of GE HealthCare's solutions?

Their solutions aim to reduce clinical complexities and enhance healthcare delivery.

Where will HIMSS 2026 take place?

HIMSS 2026 will be held in Las Vegas from March 9-12, 2026.

Last updated: Mar 5, 2026